Infections and anti-tumor necrosis factor alpha therapy.
Ellerin
Todd
T
Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Rubin
Robert H
RH
Weinblatt
Michael E
ME
D000276:Adjuvants, Immunologic / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D009894:Opportunistic Infections / Q000209:etiology* / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000276:immunology
D000276:Adjuvants, Immunologic; D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha